pharmacokinetics
| 4 min read
MSD initiates a Phase 1 trial of Cyprumed's oral peptide platform designed to reduce food-effect variability
| 5 min read
Clinical trial insights refine early-stage toxicology evaluations, yielding safer medicines.
Available on Demand
Researchers harness pharmacogenomics to understand why individual patients react differently to opioids for pain relief.
Page 1 of 1 - 3 Total Items
